1. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
- Author
-
Siddiqi, Omar K, Birbeck, Gretchen L, Ghebremichael, Musie, Mubanga, Eugene, Love, Shawn, Buback, Clayton, Kosloff, Barry, Ayles, Helen, Atadzhanov, Masharip, Dheda, Keertan, and Koralnik, Igor J
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,HIV/AIDS ,Tuberculosis ,Clinical Research ,Rare Diseases ,4.2 Evaluation of markers and technologies ,Detection ,screening and diagnosis ,Infection ,Good Health and Well Being ,Adult ,Female ,Glucose ,HIV Infections ,Humans ,Immunoassay ,Lipopolysaccharides ,Male ,Middle Aged ,Molecular Diagnostic Techniques ,Mycobacterium tuberculosis ,Prospective Studies ,Reagent Strips ,Reproducibility of Results ,Sensitivity and Specificity ,Tuberculosis ,Meningeal ,Zambia ,Africa ,LAM ,tuberculous meningitis ,Xpert MTB/RIF ,human immunodeficiency virus ,Biological Sciences ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Microbiology ,Clinical sciences ,Medical microbiology - Abstract
Tuberculous meningitis (TBM) is a devastating infection of the central nervous system lacking an adequate point-of-care diagnostic test. We conducted a prospective cohort study of 550 Zambian adults with suspected TBM to determine the diagnostic accuracy of cerebrospinal fluid (CSF) Xpert MTB/RIF, CSF lipoarabinomannan (LAM), urine LAM, CSF total protein, and CSF glucose compared with the gold standard of CSF culture. We categorized patients with a positive CSF tuberculosis (TB) culture as definite TBM. We also assessed inpatient and 1-year mortality on definite TBM patients when CSF Xpert MTB/RIF results were available in real time to treating physicians relative to a historical comparison cohort in whom Xpert results were not available in real time. Of the 550 patients, 474 (86.2%) were HIV-infected and 105/550 (19.1%) had definite TBM based on a positive CSF culture. The sensitivity/specificity of the diagnostic tests were CSF Xpert MTB/RIF, 52.9%/94.2%; CSF LAM, 21.9%/94.2%; urine LAM, 24.1%/76.1%; and CSF glucose 100 mg/dl, 66.3%/90%. A model including CSF Xpert MTB/RIF, CSF LAM, CSF glucose, and CSF total protein demonstrated an area under the receiver operating curve of 0.90. The inpatient and 1-year mortality for definite TBM was 43% and 57%, respectively. There was low sensitivity for the diagnosis of TBM across all diagnostics tests. CSF Xpert MTB/RIF and CSF LAM are highly specific for the diagnosis of TBM. Despite the use of Xpert MTB/RIF for diagnostic purpose in real time, TBM was still associated with a high mortality in Zambian patients.
- Published
- 2019